News by Subject Medicine & Health

A recently identified mechanism in the immune system reveals a previously unknown protein that could provide an opening to a better understanding of infections and autoimmune diseases. This is shown by a new basic research study from Aarhus University, Denmark.

Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already widespread in South-East Asia, but it had not previously been described in Africa. Scientists from the Institut Pasteur recently detected the emergence and spread of malaria parasites capable of resisting artemisinin derivatives for the first time in Rwanda.

Researchers in China identified four key population categories useful in guiding COVID-19 public health policies aimed at minimizing the spread of the disease and reducing fatalities. The team, led by Dr. Baoguo Jiang of the Department of Orthopedics & Traumatology at Peking University People's Hospital, published their findings in the journal Precision Clinical Medicine on May 28.

JAMA Surgery Editor Melina Kibbe, M.D., writes in this editorial: "The implications of these data demonstrating that fewer women are submitting manuscripts to JAMA Surgery during the pandemic are potentially far reaching. First and foremost, the adverse effect of the pandemic on the academic career progression of women may be significant.

As the COVID-19 pandemic continues to spread, scientists and health care providers are seeking ways to keep the coronavirus from infecting tissues once they're exposed. A new study suggests luring the virus with a decoy -- an engineered, free-floating receptor protein - binds the virus and blocks infection.

A new study led by scientists at La Jolla Institute for Immunology (LJI) shows that memory helper T cells that recognize common cold coronaviruses also recognize matching sites on SARS-CoV-2, the virus that causes COVID-19.